Schlömer, Sabine http://orcid.org/0000-0001-8237-8004
Felsberg, Jörg
Pertz, Milena
Hentschel, Bettina
Löffler, Markus
Schackert, Gabriele
Krex, Dietmar
Juratli, Tareq
Tonn, Joerg Christian
Schnell, Oliver
Vatter, Hartmut
Simon, Matthias
Westphal, Manfred
Martens, Tobias
Sabel, Michael
Bendszus, Martin
Dörner, Nils
Fliessbach, Klaus
Hoppe, Christian
Reifenberger, Guido
Weller, Michael
Schlegel, Uwe
Network, for the German Glioma
Funding for this research was provided by:
Universitätsklinikum Knappschaftskrankenhaus Bochum GmbH
Article History
Received: 11 April 2022
Accepted: 21 May 2022
First Online: 7 July 2022
Declarations
:
: Uwe Schlegel received honoraria from GlaxoSmithKline (GSK), Novartis and medac. As authors of the NeuroCog FX program, Christian Hoppe and Klaus Fliessbach received software licence fees from Eisai Inc. (Frankfurt/M., Germany). The other authors have no financial or non-financial interests to disclose.
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional local ethics boards of participating centers, with the ethics committee of the university of the leading institution in Tübingen, Germany (Registration No.: 353/2003V) and with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.